The impact of first and further decompensation in patients with metabolic-dysfunction associated compensated advanced chronic liver disease

被引：0

作者：

Pennisi, G. ^{[1
]}

Di Maria, G. ^{[2
]}

Wong, V. Wai-Sun ^{[3
]}

de Ledinghen, V. ^{[4
]}

Sebastiani, G. ^{[5
]}

Vigano, M. ^{[6
]}

Fracanzani, A. L. ^{[7
]}

Miele, L. ^{[8
]}

Bugianesi, E. ^{[9
]}

Ekstedt, M. ^{[10
]}

D'Ambrosio, R. ^{[11
]}

Schepis, F. ^{[12
,13
]}

Marra, F. ^{[14
,15
]}

Aghemo, A. M. ^{[16
]}

Svegliati-Baroni, G. ^{[17
]}

Persico, M. ^{[18
]}

Valenti, L. ^{[7
,19
]}

Berzigotti, A. ^{[20
]}

George, J. ^{[21
]}

Ravaioli, F. ^{[22
]}

Armandi, A. ^{[9
]}

Calvaruso, V. ^{[1
]}

Enea, M. ^{[2
]}

Lin, H. ^{[3
]}

Infantino, G. ^{[1
]}

Masarone, M. ^{[18
]}

Pugliese, N. ^{[16
]}

Tulone, A. ^{[1
]}

Di Marco, V. ^{[1
]}

Camma, C. ^{[1
]}

Petta, S. ^{[1
]}

机构：

[1] Univ Palermo, Sect Gastroenterol & Hepatol, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[2] Univ Palermo, Dipartimento Promoz Salute Materno Infantile Med, Palermo, Italy

[3] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China

[4] Bordeaux Univ Hosp, Hop Haut Leveque, INSERM U1053, Ctr Invest Fibrose Hepat, Pessac, France

[5] McGill Univ, Div Gastroenterol & Hepatol, Ctr Hlth, Montreal, PQ, Canada

[6] Univ Milan, Osped San Giuseppe, Hepatol Unit, Milan, Italy

[7] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[8] Fdn Policlin Gemelli IRCCS, DiSMeC Dept Sci Med & Chirurg, I-00168 Rome, Italy

[9] Univ Torino, Dept Med Sci, Div Gastroenterol, Turin, Italy

[10] Linkoping Univ, Dept Hlth Med & Caring Sci, Div Diagnost & Specialist Med, Linkoping, Sweden

[11] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Div Gastroenterol & Hepatol, Milan, Italy

[12] Azienda Osped Univ Modena, Div Gastroenterol, Modena, Italy

[13] Univ Modena & Reggio Emilia, Modena, Italy

[14] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy

[15] Res Ctr DENOTHE, Florence, Italy

[16] IRCCS Humanitas Res Hosp, Dept Gastroenterol, Div Internal Med & Hepatol, I-20089 Rozzano, Italy

[17] Univ Politecn Marche, Liver Injury & Transplant Unit, I-60121 Ancona, Italy

[18] Univ Salerno, Internal Med & Hepatol Unit, Scuola Med Salernitana, Dept Med & Surg, Salerno, Italy

[19] Fdn IRCCS Ca Granda Osped Maggiore Policlin IRCCS, Dept Transfus Med, Translat Med, Milan, Italy

[20] Univ Bern, Bern Univ Hosp, Inselspital, Dept Visceral Surg & Med, Bern, Switzerland

[21] Univ Sydney, Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia

[22] IRCCS Azienda Osped Univ Bologna, Div Internal Med Hepatobiliary & Immunoallerg Dis, Bologna, Italy

来源：

DIGESTIVE AND LIVER DISEASE | 2024年 / 56卷

关键词：

D O I：

10.1016/j.dld.2024.08.005

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

OC-01

引用

页码：S316 / S317

页数：2

共 50 条

[31] Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease
Gao, Zhifeng
Deng, Huan
Qin, Bowen
Bai, Liang
Li, Jiangwei
Zhang, Jian
FRONTIERS IN MEDICINE, 2025, 12
[32] Sarcopenia in metabolic-dysfunction associated steatotic liver disease (MASLD): unraveling its role in cardiovascular damage
Cespiati, Annalisa
Lombardi, Rosa
Sigon, Giordano
Santomenna, Floriana
Carlomagno, Matteo
Couffon, Margaux
Martino, Beatrice
Huang, Jian
Smith, Daniel
Pisano, Giuseppina
Oberti, Giovanna
Forlano, Roberta
Manousou, Pinelopi
Petta, Salvatore
Fracanzani, Anna Ludovica
JOURNAL OF HEPATOLOGY, 2024, 80 : S466 - S467
[33] PARENTAL OBESITY AT PREGNANCY WITH RISK OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN YOUNG ADULT OFFSPRING
Tica, Stefani
Zong, Xiaoyu
Tarr, Phillip I.
Cao, Yin
GASTROENTEROLOGY, 2024, 166 (05) : S26 - S27
[34] Prevalence of diagnosed advanced liver fibrosis in high-risk population with metabolic-dysfunction associated fatty liver disease screened in diabetology using transient elastography
Aubin, Adrien
Maynard, Marianne
Segrestin, Berenice
Chouik, Yasmina
Milot, Laurent
Hervieu, Valerie
Zoulim, Fabien
Disse, Emmanuel
Levrero, Massimo
Caussy, Cyrielle
JOURNAL OF HEPATOLOGY, 2023, 78 : S687 - S688
[35] Impact of semaglutide on biochemical and radiologic measures of metabolic-dysfunction associated fatty liver disease across the spectrum of glycaemia: A meta-analysis
Dutta, Deep
Kumar, Manoj
Shivaprasad, K. S.
Kumar, Ashok
Sharma, Meha
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2022, 16 (06)
[36] GUT MYCOBIOME IN THE SPECTRUM OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE (MASLD): FROM MASH TO HEPATOCELLULAR CARCINOMA
Alvares-da-Silva, Mario
Perlin, Cassio
Keingeski, Melina
Basso, Bruno
Medeiros, Juliane
Borges, Francis
Uribe-Cruz, Carolina
HEPATOLOGY, 2024, 80 : S669 - S670
[37] THE STRUGGLE TO DIAGNOSE METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN CHILDREN: HIGH DISSOCIATION BETWEEN LIVER IMAGING AND BIOCHEMISTRIES
Beauchamp, Giovanna
Bril, Fernando
HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 279 - 280
[38] Diet quality and physical activity affect metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction and etiology-associated steatohepatitis, and compensated advanced chronic liver disease among United States adults: NHANES 2017-2020
Wang, Peng
Xia, Bingxin
Wang, Shuang
FRONTIERS IN NUTRITION, 2025, 11
[39] Baveno VII criteria to predict decompensation in compensated advanced chronic liver disease: Still some shades of grey
Rodrigues, Susana G.
CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 110 - 112
[40] ULTRASOUND-GUIDED PORTAL PRESSURE GRADIENT MEASUREMENT AND CLINICAL INDICATORS OF PORTAL HYPERTENSION IN PATIENTS WITH CHRONIC LIVER DISEASE DUE TO METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE VS OTHER ETIOLOGIES
Dougherty, Diana
Abel, William
Bapaye, Jay
Yeaton, Paul
Kesar, Varun
Kesar, Vivek
GASTROINTESTINAL ENDOSCOPY, 2024, 99 (06) : AB855 - AB855

← 1 2 3 4 5 →